Blood pressure and heart rate response evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine II. A quantitative assessment of the role of amphetamine metabolites in acute responses evoked by d-amphetamine
- PMID: 7205614
Blood pressure and heart rate response evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine II. A quantitative assessment of the role of amphetamine metabolites in acute responses evoked by d-amphetamine
Abstract
At postganglionic sympathetic sites, p-hydroxyamphetamine is neither a receptor agonist nor a receptor antagonist; in addition the drug does not act presynaptically to antagonize or synergize d-amphetamine. p-Hydroxyamphetamine is an indirectly acting sympathomimetic amine with a potency approximately twice that of d-amphetamine. In the rat, a large fraction (approximately 0.5) of d-amphetamine is biotransformed to p-hydroxyamphetamine. However, the rate of biotransformation to p-hydroxyamphetamine (approximately 0.0099 . min-1) is slow compared to the rate of elimination of p-hydroxyamphetamine (0.049 . min-1). As a result, plasma levels of d-amphetamine exceed those of p-hydroxyamphetamine. The kinetic data suggest that: 1) p-hydroxyamphetamine plays little role in immediate responses to single injections of d-amphetamine; 2) p-hydroxyamphetamine is not involved in tachyphylactic responses to repeated injections of d-amphetamine; and 3) p-hydroxynorephedrine plays no role in immediate or tachyphylactic responses to d-amphetamine.
Similar articles
-
Blood pressure and heart rate responses evoked by p-hydroxyamphetamine and by p-hydroxynorephedrine. I. The relationship between evoked responses and plasma levels of drug.J Pharmacol Exp Ther. 1979 Oct;211(1):225-30. J Pharmacol Exp Ther. 1979. PMID: 40013 No abstract available.
-
Neurochemical effects of amphetamine metabolites on central dopaminergic and serotonergic systems.J Pharmacol Exp Ther. 1989 Dec;251(3):901-8. J Pharmacol Exp Ther. 1989. PMID: 2600821
-
Inhibition of brain type A monoamine oxidase and 5-hydroxytryptamine uptake by two amphetamine metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine.J Neurochem. 1990 Aug;55(2):403-8. doi: 10.1111/j.1471-4159.1990.tb04151.x. J Neurochem. 1990. PMID: 2370545
-
Properties of dopamine efflux from rat striatal tissue caused by amphetamine and p-hydroxyamphetamine.Proc West Pharmacol Soc. 1976;19:179-82. Proc West Pharmacol Soc. 1976. PMID: 995984 No abstract available.
-
d-Amphetamine interaction with glutathione in freshly isolated rat hepatocytes.Chem Res Toxicol. 1996 Sep;9(6):1031-6. doi: 10.1021/tx9501750. Chem Res Toxicol. 1996. PMID: 8870992
Cited by
-
Central administration of p-hydroxyamphetamine produces a behavioral stimulant effect in rodents: evidence for the involvement of dopaminergic systems.Psychopharmacology (Berl). 2010 Feb;208(2):323-31. doi: 10.1007/s00213-009-1734-x. Epub 2009 Dec 4. Psychopharmacology (Berl). 2010. PMID: 19960188
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Research Materials
Miscellaneous